France Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin DeliveryReport Details:Published:Septem...
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth....
5.3 Insulin Delivery Market, France, Segment Contribution (%), 2011 425.4 Insulin Delivery Overall Revenue, (2004-2018) 43...
6.13.1 Company Overview 766.14 B. Braun Melsungen AG 776.14.1 Company Overview 776.15 Nipro Corporation 776.15.1 Company O...
Table 9: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 27Table 10: Blood Glucose ...
Table 37: Diabetes Care Devices Market Pipeline Products 78Table 38: Insulet Expands Distribution Agreement With Ypsomed H...
2018 49Figure 28: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 51Figure 29: Insul...
Upcoming SlideShare
Loading in …5
×

France Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

124 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
124
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

France Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  1. 1. France Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 89Price: Single User License – US$2500France Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “France Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the France Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the France Diabetes CareDevicesmarket.- Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi, NovoNordisk A/S, LifeScan, Inc., Medtronic, Inc. and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the France Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197488-france-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In France 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, France, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, France, Category Contribution (%), 2011 133.5 Diabetes Care Devices, France, Company Share (2010-2011) 194 Glucose Monitoring In France 214.1 Glucose Monitoring, Market Segmentation 214.2 Glucose Monitoring Market, France, Revenue Mix ($m), 2011 224.3 Glucose Monitoring Market, France, Segment Contribution (%), 2011 234.4 Glucose Monitoring Overall Revenue, (2004-2018) 244.4.1 Blood Glucose Meters, Revenue (2004-2018) 284.5 Glucose Monitoring Overall Volume (2004-2018) 324.5.1 Blood Glucose Meters, Volume (2004-2018) 344.6 Glucose Monitoring Average Price (2004-2018) 364.7 Glucose Monitoring Distribution Share (2010-2011) 374.8 Glucose Monitoring, France, Company Share (2010-2011) 385 Insulin Delivery In France 405.1 Insulin Delivery, Market Segmentation 405.2 Insulin Delivery Market, France, Revenue Mix ($m), 2011 41
  3. 3. 5.3 Insulin Delivery Market, France, Segment Contribution (%), 2011 425.4 Insulin Delivery Overall Revenue, (2004-2018) 435.4.1 Insulin Pens, Revenue (2004-2018) 475.4.2 Insulin Pumps, Revenue (2004-2018) 515.5 Insulin Delivery Overall Volume (2004-2018) 555.5.1 Insulin Pens, Volume (2004-2018) 585.5.2 Insulin Pumps, Volume (2004-2018) 605.6 Insulin Delivery Average Price (2004-2018) 645.7 Insulin Delivery Distribution Share (2010-2011) 655.8 Insulin Delivery, France, Company Share (2010-2011) 666 Overview of Key Companies in France Diabetes Care Devices Market 686.1 F. Hoffmann-La Roche Ltd. 686.1.1 Company Overview 686.1.2 Share in the France Diabetes Care Devices Market 686.2 Eli Lilly and Company 696.2.1 Company Overview 696.2.2 Share in the France Diabetes Care Devices Market 696.3 Sanofi 706.3.1 Company Overview 706.3.2 Share in the France Diabetes Care Devices Market 706.4 Novo Nordisk A/S 716.4.1 Company Overview 716.4.2 Share in the France Diabetes Care Devices Market 716.5 LifeScan, Inc. 726.5.1 Company Overview 726.5.2 Share in the France Diabetes Care Devices Market 726.6 Medtronic, Inc. 736.6.1 Company Overview 736.6.2 Share in the France Diabetes Care Devices Market 736.7 Bayer HealthCare AG 746.7.1 Company Overview 746.8 Abbott Laboratories 746.8.1 Company Overview 746.9 Becton, Dickinson and Company 756.9.1 Company Overview 756.10 Animas Corporation 756.10.1 Company Overview 756.11 Ypsomed Holding AG 756.11.1 Company Overview 756.12 ARKRAY, Inc. 766.12.1 Company Overview 766.13 Terumo Corporation 76
  4. 4. 6.13.1 Company Overview 766.14 B. Braun Melsungen AG 776.14.1 Company Overview 776.15 Nipro Corporation 776.15.1 Company Overview 777 Diabetes Care Devices Market Pipeline Products 788 Financial Deals Landscape 828.1 Partnerships 828.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 829 Recent Developments 839.1 Strategy And Business Planning 839.1.1 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 839.2 Product News 839.2.1 Feb 14, 2008: Sanofi-aventis’ SoloSTAR Insulin Pen For Lantus And Apidra Receives TheGOOD DESIGN Award 8310 Appendix 8410.1 Definitions of Markets Covered in the Report 8510.1.1 Diabetes Care Devices 8510.2 Research Methodology 8710.3 Secondary Research 8710.4 Primary Research 8810.5 Models 8810.6 Forecasts 8810.7 Expert Panels 8910.8 GlobalData Consulting 8910.9 Currency Conversion 8910.10 Contact Us 8910.11 Disclaimer 891.1 List of TablesTable 1: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 11Table 2: Diabetes Care Devices Market, France, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, France, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Table 5: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18Table 6: Diabetes Care Devices, France, Company Share by Revenue ($m), USD Constant, 2010-2011 20Table 7: Glucose Monitoring Market, France, Segment Contribution (%), 2011 23Table 8: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 25
  5. 5. Table 9: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 27Table 10: Blood Glucose Meters, France, Revenue ($m*) USD Constant, by Sub-Segment,Historic, 2004-2011 29Table 11: Blood Glucose Meters, France, Revenue ($m*) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Table 12: Glucose Monitoring, France, Volume (Units) by Segment, Historic, 2004-2011 32Table 13: Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2011-2018 33Table 14: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 34Table 15: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Forecast, 2011-201835Table 16: Glucose Monitoring, France, Average Price ($), Historic, 2004-2011 36Table 17: Glucose Monitoring, France, Average Price ($), Forecast, 2011-2018 36Table 18: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 37Table 19: Glucose Monitoring, France, Company Share by Revenue ($m), USD Constant, 2010-2011 39Table 20: Insulin Delivery Market, France, Segment Contribution (%), 2011 42Table 21: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-201144Table 22: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 46Table 23: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48Table 24: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50Table 25: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52Table 26: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 54Table 27: Insulin Delivery, France, Volume (Units) by Segment, Historic, 2004-2011 56Table 28: Insulin Delivery, France, Volume (Units) by Segment, Forecast, 2011-2018 57Table 29: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Table 30: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Table 31: Insulin Pumps, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Table 32: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63Table 33: Insulin Delivery, France, Average Price ($), Historic, 2004-2011 64Table 34: Insulin Delivery, France, Average Price ($), Forecast, 2011-2018 64Table 35: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 65Table 36: Insulin Delivery, France, Company Share by Revenue ($m), USD Constant, 2010-201167
  6. 6. Table 37: Diabetes Care Devices Market Pipeline Products 78Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 821.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices Market, France, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, France, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, France, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Figure 7: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17Figure 8: Diabetes Care Devices, France, Company Share (%)-2011 19Figure 9: Glucose Monitoring, Market Segmentation 21Figure 10: Glucose Monitoring Market, France, Revenue Mix ($m), 2011 22Figure 11: Glucose Monitoring Market, France, Segment Contribution (%), 2011 23Figure 12: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 24Figure 13: Glucose Monitoring, France, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 26Figure 14: Blood Glucose Meters, France, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 28Figure 15: Blood Glucose Meters, France, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 30Figure 16: Glucose Monitoring, France, Volume (Units) by Segment, Historic, 2004-2011 32Figure 17: Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2011-2018 33Figure 18: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Historic, 2004-201134Figure 19: Blood Glucose Meters, France, Volume (Units) by Sub-Segment, Forecast, 2011-201835Figure 20: Glucose Monitoring, France, Company Share (%), 2011 38Figure 21: Insulin Delivery, Market Segmentation 40Figure 22: Insulin Delivery Market, France, Revenue Mix ($m), 2011 41Figure 23: Insulin Delivery Market, France, Segment Contribution (%), 2011 42Figure 24: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 43Figure 25: Insulin Delivery, France, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 45Figure 26: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 47Figure 27: Insulin Pens, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
  7. 7. 2018 49Figure 28: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 51Figure 29: Insulin Pumps, France, Revenue ($m) USD Constant, by Sub-Segment, Forecast,2011-2018 53Figure 30: Insulin Delivery, France, Volume (Units) by Segment, Historic, 2004-2011 55Figure 31: Insulin Delivery, France, Volume (Units) by Segment, Forecast, 2011-2018 57Figure 32: Insulin Pens, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 58Figure 33: Insulin Pens, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 59Figure 34: Insulin Pumps, France, Volume (Units) by Sub-Segment, Historic, 2004-2011 60Figure 35: Insulin Pumps, France, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Figure 36: Insulin Delivery, France, Company Share (%), 2011 66Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),France Diabetes Care DevicesMarket, 2011 68Figure 38: Eli Lilly and Company, Company Share (%),France Diabetes Care Devices Market,2011 69Figure 39: Sanofi, Company Share (%),France Diabetes Care Devices Market, 2011 70Figure 40: Novo Nordisk A/S, Company Share (%),France Diabetes Care Devices Market, 201171Figure 41: LifeScan, Inc., Company Share (%),France Diabetes Care Devices Market, 2011 72Figure 42: Medtronic, Inc., Company Share (%),France Diabetes Care Devices Market, 2011 73Contact: sales@reportsandreports.com for more information.

×